Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1037389 NEW YORK, NY
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$37,320,742
+$25,996,044 QoQ
Shares Held
679,300
+99.3% QoQ
Ownership
0.444%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#29
of 426 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. TGTX ranks #20 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in TGTX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,320,742 679,300
2026-03-31 $11,324,698 340,900
2025-03-31 $6,647,661 168,594
2024-06-30 $5,503,710 309,371
2024-03-31 $12,785,526 840,600
2023-12-31 $14,333,536 839,200
2023-09-30 $11,507,222 1,376,462
2023-06-30 $13,319,208 536,200
2022-12-31 $1,172,353 99,100
2022-09-30 $1,060,864 179,200
2022-06-30 $5,019,675 1,181,100
2022-03-31 $1,879,176 197,600
2021-12-31 $4,734,800 249,200
2021-06-30 $5,655,582 145,800
2021-03-31 $6,458,800 134,000
2020-12-31 $19,143,360 368,000
2020-09-30 $2,638,536 98,600
2020-06-30 $22,507,192 1,155,400
2020-03-31 $5,036,112 511,800